Da: California Books, Miami, FL, U.S.A.
EUR 22,83
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: California Books, Miami, FL, U.S.A.
EUR 32,49
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Best Price, Torrance, CA, U.S.A.
EUR 16,20
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloCondizione: New. SUPER FAST SHIPPING.
Editore: Creative Media Partners, LLC Mai 2025, 2025
ISBN 10: 1025097327 ISBN 13: 9781025097329
Lingua: Inglese
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 30,36
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware - Novel properties of engineered nanoparticles that make them attractive may also present unique exposure risks. The traditional physiologically-based pharmacokinetic (PBPK) modeling assumption of instantaneous equilibration likely does not apply to nanoparticles. This simulation-based research begins with development of a model that includes di usion, active transport, and carrier mediated transport. Eigenvalue analysis was used to examine model behavior to focus future research. Results show that cellular transport processes greatly a ect biokinetics of nanoparticles. The new paradigm established by this research leverages traditional in vitro, in vivo, and PBPK modeling, but includes area under the curve to bridge animal testing results to humans. This allows assessment of risk and assists in setting appropriate exposure limits. The model provides critical understanding of nanoparticle biokinetics and allows estimation of total exposure. This e ort highlights future research needs and demonstrates how modeling can be used as a tool to advance nanoparticle risk assessment.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 30,16
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Best Price, Torrance, CA, U.S.A.
EUR 25,70
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloCondizione: New. SUPER FAST SHIPPING.
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 34,55
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 35,95
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Books Puddle, New York, NY, U.S.A.
EUR 46,13
Convertire valutaQuantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
Da: Books Puddle, New York, NY, U.S.A.
EUR 48,07
Convertire valutaQuantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
Editore: LAP Lambert Academic Publishing, 2009
ISBN 10: 3838309707 ISBN 13: 9783838309705
Lingua: Inglese
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 46,88
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Editore: LAP Lambert Academic Publishing, 2009
ISBN 10: 3838309707 ISBN 13: 9783838309705
Lingua: Inglese
Da: California Books, Miami, FL, U.S.A.
EUR 50,92
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 41,49
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: CitiRetail, Stevenage, Regno Unito
EUR 24,76
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: new. Paperback. Novel properties of engineered nanoparticles that make them attractive may also present unique exposure risks. The traditional physiologically-based pharmacokinetic (PBPK) modeling assumption of instantaneous equilibration likely does not apply to nanoparticles. This simulation-based research begins with development of a model that includes di usion, active transport, and carrier mediated transport. Eigenvalue analysis was used to examine model behavior to focus future research. Results show that cellular transport processes greatly a ect biokinetics of nanoparticles. The new paradigm established by this research leverages traditional in vitro, in vivo, and PBPK modeling, but includes area under the curve to bridge animal testing results to humans. This allows assessment of risk and assists in setting appropriate exposure limits. The model provides critical understanding of nanoparticle biokinetics and allows estimation of total exposure. This e ort highlights future research needs and demonstrates how modeling can be used as a tool to advance nanoparticle risk assessment.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Editore: Creative Media Partners, LLC Mai 2025, 2025
ISBN 10: 1025093011 ISBN 13: 9781025093017
Lingua: Inglese
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 46,55
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware - Novel properties of engineered nanoparticles that make them attractive may also present unique exposure risks. The traditional physiologically-based pharmacokinetic (PBPK) modeling assumption of instantaneous equilibration likely does not apply to nanoparticles. This simulation-based research begins with development of a model that includes di usion, active transport, and carrier mediated transport. Eigenvalue analysis was used to examine model behavior to focus future research. Results show that cellular transport processes greatly a ect biokinetics of nanoparticles. The new paradigm established by this research leverages traditional in vitro, in vivo, and PBPK modeling, but includes area under the curve to bridge animal testing results to humans. This allows assessment of risk and assists in setting appropriate exposure limits. The model provides critical understanding of nanoparticle biokinetics and allows estimation of total exposure. This e ort highlights future research needs and demonstrates how modeling can be used as a tool to advance nanoparticle risk assessment.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 54,09
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Editore: LAP Lambert Academic Publishing, 2009
ISBN 10: 3838309707 ISBN 13: 9783838309705
Lingua: Inglese
Da: Best Price, Torrance, CA, U.S.A.
EUR 41,37
Convertire valutaQuantità: 4 disponibili
Aggiungi al carrelloCondizione: New. SUPER FAST SHIPPING.
Editore: LAP Lambert Academic Publishing 2009-08-26, 2009
ISBN 10: 3838309707 ISBN 13: 9783838309705
Lingua: Inglese
Da: Chiron Media, Wallingford, Regno Unito
EUR 44,31
Convertire valutaQuantità: 10 disponibili
Aggiungi al carrelloPaperback. Condizione: New.
Da: Best Price, Torrance, CA, U.S.A.
EUR 45,26
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloCondizione: New. SUPER FAST SHIPPING.
Da: CitiRetail, Stevenage, Regno Unito
EUR 35,96
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. Novel properties of engineered nanoparticles that make them attractive may also present unique exposure risks. The traditional physiologically-based pharmacokinetic (PBPK) modeling assumption of instantaneous equilibration likely does not apply to nanoparticles. This simulation-based research begins with development of a model that includes di usion, active transport, and carrier mediated transport. Eigenvalue analysis was used to examine model behavior to focus future research. Results show that cellular transport processes greatly a ect biokinetics of nanoparticles. The new paradigm established by this research leverages traditional in vitro, in vivo, and PBPK modeling, but includes area under the curve to bridge animal testing results to humans. This allows assessment of risk and assists in setting appropriate exposure limits. The model provides critical understanding of nanoparticle biokinetics and allows estimation of total exposure. This e ort highlights future research needs and demonstrates how modeling can be used as a tool to advance nanoparticle risk assessment.This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Da: Books Puddle, New York, NY, U.S.A.
EUR 64,60
Convertire valutaQuantità: 4 disponibili
Aggiungi al carrelloCondizione: New. pp. 208.
Da: Books Puddle, New York, NY, U.S.A.
EUR 64,79
Convertire valutaQuantità: 4 disponibili
Aggiungi al carrelloCondizione: New. pp. 216.
Da: moluna, Greven, Germania
EUR 61,74
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. KlappentextrnrnNovel properties of engineered nanoparticles that make them attractive may also present unique exposure risks. The traditional physiologically-based pharmacokinetic (PBPK) modeling assumption of instantaneous equilibration likely .
Da: Chiron Media, Wallingford, Regno Unito
EUR 50,46
Convertire valutaQuantità: 10 disponibili
Aggiungi al carrelloPF. Condizione: New.
Editore: Creative Media Partners, LLC Okt 2012, 2012
ISBN 10: 1249831016 ISBN 13: 9781249831013
Lingua: Inglese
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 74,86
Convertire valutaQuantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware - Novel properties of engineered nanoparticles that make them attractive may also present unique exposure risks. The traditional physiologically-based pharmacokinetic (PBPK) modeling assumption of instantaneous equilibration likely does not apply to nanoparticles. This simulation-based research begins with development of a model that includes di usion, active transport, and carrier mediated transport. Eigenvalue analysis was used to examine model behavior to focus future research. Results show that cellular transport processes greatly a ect biokinetics of nanoparticles. The new paradigm established by this research leverages traditional in vitro, in vivo, and PBPK modeling, but includes area under the curve to bridge animal testing results to humans. This allows assessment of risk and assists in setting appropriate exposure limits. The model provides critical understanding of nanoparticle biokinetics and allows estimation of total exposure. This e ort highlights future research needs and demonstrates how modeling can be used as a tool to advance nanoparticle risk assessment.
Da: Alplaus Books, Alplaus, NY, U.S.A.
EUR 54,70
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrellohardcover. Condizione: Good. Hardcover. Pages unmarked, gentle cover wear.
Da: ThriftBooks-Atlanta, AUSTELL, GA, U.S.A.
EUR 85,01
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 1.6.
Editore: LAP Lambert Academic Publishing, 2009
ISBN 10: 3838309707 ISBN 13: 9783838309705
Lingua: Inglese
Da: Lucky's Textbooks, Dallas, TX, U.S.A.
EUR 45,74
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Lucky's Textbooks, Dallas, TX, U.S.A.
EUR 49,12
Convertire valutaQuantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Editore: Wiley-Interscience (edition 1), 2005
ISBN 10: 0471478148 ISBN 13: 9780471478140
Lingua: Inglese
Da: BooksRun, Philadelphia, PA, U.S.A.
EUR 82,26
Convertire valutaQuantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Good. 1. It's a preowned item in good condition and includes all the pages. It may have some general signs of wear and tear, such as markings, highlighting, slight damage to the cover, minimal wear to the binding, etc., but they will not affect the overall reading experience.